ACE2016
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACE2016, covering 2025-07-01 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) [Phase 1]